Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
Duravelo-3
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
- NCT06840483 ↗
- Active, not recruiting
- BicycleTx Limited
- Focused
We haven't built an HCP commentary report on Duravelo-3 (zelenectide pevedotin in Breast Cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on Duravelo-3 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 5 |
The trial
ClinicalTrials.gov- Official title
- Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Zelenectide pevedotin (BT8009)
- Arms
- Cohort A (HR+/HER2-negative breast cancer) · Experimental
- Cohort B (TNBC) · Experimental
- Enrollment
- 66 (estimated)
- Primary outcomes
- Objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors per RECIST version 1.1 as assessed by the Investigator
- Sponsor
- BicycleTx Limited
- Start
- Mar 3, 2025
- Primary completion
- Jun 30, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06840483 · updated Apr 15, 2026